New LIHTI tenant announces $12m Series B venture financing

Coferon, a biotech firm newly based at our supporting member the Long Island High Technology Incubator at Stony Brook University, announced a $12 million Series B financing provided by three prominent venture-capital firms.

Coferon is developing "self-assembling" active pharmaceutical ingredients optimized for specific diseases. The firm is led by former executives of OSI Pharmaceuticals, also of Long Island, and one of its scientific founders is a faculty member at Weill Cornell Medical College in New York City.

For more information, please see the company's news release and coverage in Long Island's ThreeVillage Patch.